1. Home
  2. NPCE vs ALLO Comparison

NPCE vs ALLO Comparison

Compare NPCE & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$7.95

Market Cap

490.2M

Sector

Health Care

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$0.81

Market Cap

452.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPCE
ALLO
Founded
1997
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
490.2M
452.6M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
NPCE
ALLO
Price
$7.95
$0.81
Analyst Decision
Buy
Strong Buy
Analyst Count
10
12
Target Price
★ $14.11
$9.00
AVG Volume (30 Days)
376.2K
★ 11.2M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
29.03
★ 34.09
EPS
N/A
★ N/A
Revenue
★ $99,986,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.75
$72.02
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 25.13
N/A
52 Week Low
$5.46
$0.82
52 Week High
$19.60
$4.46

Technical Indicators

Market Signals
Indicator
NPCE
ALLO
Relative Strength Index (RSI) 23.99 22.86
Support Level N/A N/A
Resistance Level $14.90 $2.25
Average True Range (ATR) 0.85 0.10
MACD -0.47 -0.02
Stochastic Oscillator 28.83 4.06

Price Performance

Historical Comparison
NPCE
ALLO

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

Share on Social Networks: